microRNA 3124 (MIR3124)

microRNA 3124 (MIR3124) is classified as a human microRNA—a short, non-coding RNA molecule (approximately 21–23 nucleotides in length) involved in post-transcriptional regulation of gene expression by base-pairing with complementary sequences in target messenger RNAs, usually leading to translational inhibition or mRNA degradation[1][3]. However, there is no evidence in the current biomedical literature or key databases to suggest that MIR3124 is a well-characterized or functionally annotated microRNA, nor is there supportive information indicating its role as a therapeutic target, disease biomarker, or drug-interactable molecule. Additional context and justification: - While microRNAs as a category are well-established regulators in numerous physiological and disease processes—including cancer, cell cycle, and neurological diseases[1][2][5]—there is no published characterization, known function, or clinical significance established specifically for MIR3124 (microRNA 3124) in human or animal systems based on available evidence. - Major microRNA databases such as miRBase and MirGeneDB have inconsistent or absent data on MIR3124, suggesting it is not a validated or widely recognized microRNA subtype. Its inclusion may represent an uncurated, computationally predicted, or possibly misannotated sequence (hence, is_incorrect: true). - If you are seeking microRNA drug targets, regulatory RNAs, or therapeutic biomarkers, canonical and functionally validated microRNAs would be preferred. Currently, MIR3124 does not fit this criterion. If more specific or validated information about a different microRNA target is needed, providing an alternative gene or microRNA name is recommended.

Other names

hsa-mir-3124mir-3124MIR3124